Suppr超能文献

一种具有降低神经元复制能力的阿昔洛韦抗性单纯疱疹病毒 1 胸苷激酶替代突变体,可有效地建立可激活的潜伏状态。

Efficient establishment of reactivatable latency by an acyclovir-resistant herpes simplex virus 1 thymidine kinase substitution mutant with reduced neuronal replication.

机构信息

Department of Ophthalmology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China; Key Laboratory for Corneal Diseases Research of Zhejiang Province, China.

Department of Medical Microbiology and Parasitology, and Department of Infectious Diseases of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.

出版信息

Virology. 2021 Apr;556:140-148. doi: 10.1016/j.virol.2021.01.016. Epub 2021 Feb 3.

Abstract

Herpes simplex virus 1 causes recurrent diseases by reactivating from latency, which requires the viral thymidine kinase (TK) gene. An acyclovir-resistant mutation in TK, V204G, was previously repeatedly identified in a patient with recurrent herpetic keratitis. We found that compared with its parental strain KOS, a laboratory-derived V204G mutant virus was impaired in replication in cultured neurons despite little defect in non-neuronal cells. After corneal inoculation of mice, V204G exhibited defects in ocular replication that were modest over the first three days but severe afterward. Acute replication of V204G in trigeminal ganglia was significantly impaired. However, V204G established latency with viral loads as high as KOS and reactivated with high frequency albeit reduced kinetics. Acyclovir treatment that drastically decreased ocular and ganglionic replication of KOS had little effect on V204G. Thus, despite reduced neuronal replication due to impaired TK activity, this clinically relevant drug-resistant mutant can efficiently establish reactivatable latency.

摘要

单纯疱疹病毒 1 通过从潜伏状态中重新激活而导致复发疾病,这需要病毒胸苷激酶 (TK) 基因。先前在患有复发性疱疹性角膜炎的患者中反复发现 TK 中的一种阿昔洛韦耐药突变 V204G。我们发现,与亲本株 KOS 相比,实验室衍生的 V204G 突变病毒在培养神经元中的复制受到损害,尽管在非神经元细胞中几乎没有缺陷。在角膜接种小鼠后,V204G 在眼部复制中表现出缺陷,在前三天轻微,但随后严重。V204G 在三叉神经节中的急性复制受到显著损害。然而,V204G 以与 KOS 相同的高病毒载量建立潜伏状态,并以高频率但降低动力学重新激活。阿昔洛韦治疗大大降低了 KOS 的眼部和神经节复制,但对 V204G 几乎没有影响。因此,尽管由于 TK 活性受损导致神经元复制减少,但这种具有临床相关性的耐药突变体仍能有效地建立可重新激活的潜伏状态。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验